
Faculty say heart failure patients miss iron deficiency care when no one owns it; pharmacist-led workflows may help close the gap.
The safety profile of oral semaglutide across the PIONEER trials was shown to be consistent with other glucagon-like peptide-1 receptor agonists (GLP-1RAs).
Click PLAY to watch the video abstract.
Click
Click






